NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE INJECTION

baxter corporation🇨🇦 Health Canada

Approval Id: 868e2e1e748851c5
Drug Approval Canada Name: NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE INJECTION
Product Name: NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE INJECTION
Status: Marketed
Status Date: 2021-07-20
Original Market Date: 2021-07-20
Din: 02501449
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Intravenous
Schedule: Ethical
Ahfs: 12:12.12
Atc Original: C01CA03 NOREPINEPHRINE
Atc Name: c 01 ca 03
Aig Number: 0131301003
Company Name: baxter corporation
Company Address: 7125 Mississauga Road, Mississauga, Ontario, Canada, L5N 0C2

NOREPINEPHRINE (NOREPINEPHRINE BITARTRATE)

0.032 MG / ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

868e2e1e748851c5

Type

Standard